Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Davide Dalu, Cinzia Fasola, Luca Ammoni, Davide De Francesco, Maria Silvia Cona, Selene Rota, Sabrina Ferrario, Anna Gambaro, Nicoletta Tosca, Sheila Piva & Nicla La Verde. (2021) Pegylated liposomal doxorubicin as first line treatment in aids-related Kaposi’s sarcoma: a real-life study. Journal of Chemotherapy 33:5, pages 342-347.
Read now
Read now
Francesca Cainelli & Alfredo Vallone. (2009) Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma. Biologics: Targets and Therapy 3, pages 385-390.
Read now
Read now
Ashish Udhrain, Keith M Skubitz & Donald W Northfelt. (2007) Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma. International Journal of Nanomedicine 2:3, pages 345-352.
Read now
Read now
Articles from other publishers (35)
Jane Tian, Selma Janbey, Maryam Hassanesfahani, Shubham Bhatia, Martine A Louis & Noman Khan. (2023) Kaposi sarcoma presenting as small bowel obstruction. Journal of Surgical Case Reports 2023:7.
Crossref
Crossref
Matthew E. Coldiron, Ana Gabriela Gutierrez Zamudio, Rolanda Manuel, Gilda Luciano, Barbara Rusch, Iza Ciglenecki, Alex Telnov, Rebecca F. Grais, Laurence Toutous Trellu & Lucas Molfino. (2021) Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin. Infectious Agents and Cancer 16:1.
Crossref
Crossref
H. Abi Rached, S. Javed, P. Lepesant & L. Mortier. (2019) Enfermedad de Kaposi. EMC - Dermatología 53:1, pages 1-13.
Crossref
Crossref
Vini Fardhdiani, Lucas Molfino, Ana Gabriela Zamudio, Rolanda Manuel, Gilda Luciano, Iza Ciglenecki, Barbara Rusch, Laurence Toutous Trellu & Matthew E Coldiron. (2018) HIV-associated Kaposi’s sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010–2015. Infectious Agents and Cancer 13:1.
Crossref
Crossref
Fahmida ShaikThomas S. UldrickTonya EsterhuizenAnisa Mosam. (2018) Health-Related Quality of Life in Patients Treated With Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for HIV-Associated Kaposi Sarcoma: A Randomized Control Trial. Journal of Global Oncology:4, pages 1-9.
Crossref
Crossref
Jeremy S. Abramson & David T. Scadden. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
23
.
Tetsuya ISHIKAWA, Kunio YANAGISAWA, Yoshiyuki OGAWA, Hideki UCHIUMI, Fumito GOHDA & Hiroshi HANDA. (2017) Successful Treatment of Immune Reconstitution Inflammatory Syndrome with Corticosteroid for Patient with Kaposiʼs Sarcoma Extending into the Respiratory Tract and Both Lungs免疫再構築症候群に対してステロイド治療が有効であった 高度気道狭窄合併カポジ肉腫症例. Kansenshogaku Zasshi 91:1, pages 25-30.
Crossref
Crossref
Marilia Rita Pinzone, Massimiliano Berretta, Bruno Cacopardo & Giuseppe Nunnari. (2015) Epstein-Barr Virus– and Kaposi Sarcoma-Associated Herpesvirus–Related Malignancies in the Setting of Human Immunodeficiency Virus Infection. Seminars in Oncology 42:2, pages 258-271.
Crossref
Crossref
Oluwatoyin F Gbabe, Charles I Okwundu, Martin Dedicoat & Esther E Freeman. (2014) Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Anisa Mosam, Fahmida Shaik, Thomas S. Uldrick, Tonya Esterhuizen, Gerald H. Friedland, David T. Scadden, Jamila Aboobaker & Hoosen M. Coovadia. (2012) A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes 60:2, pages 150-157.
Crossref
Crossref
Sean T. Duggan & Gillian M. Keating. (2011) Pegylated Liposomal Doxorubicin. Drugs 71:18, pages 2531-2558.
Crossref
Crossref
Karina Pupio Raimundo & Carl V. Asche. (2011) A review of the efficacy and outcomes studies of currently approved chemotherapy treatments for advanced AIDS-Kaposi's sarcoma. HIV & AIDS Review 10:3, pages 56-60.
Crossref
Crossref
Thomas S. Uldrick & Denise Whitby. (2011) Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Letters 305:2, pages 150-162.
Crossref
Crossref
Mary Cianfrocca, Sandra Lee, Jamie Von Roenn, Anil Tulpule, Bruce J. Dezube, David M. Aboulafia, Richard F. Ambinder, Jeannette Y. Lee, Susan E. Krown & Joseph A. Sparano. (2010) Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma. Cancer 116:16, pages 3969-3977.
Crossref
Crossref
M. Ulrich, C. Ulrich, Anja V. Potthoff, Norbert H. Brockmeyer, G. Schäfer-Hesterberg, Theodore Rosen, Robert Baran, Kenneth W. NealJrJr & Hugh M. GlosterJrJr. 2010. Managing Skin Cancer. Managing Skin Cancer
149
210
.
Philip E. Pellett & Sheila C. Dollard. 2009. Clinical Virology Manual. Clinical Virology Manual
494
522
.
Keith M. Skubitz & David R. D'Adamo. (2007) Sarcoma. Mayo Clinic Proceedings 82:11, pages 1409-1432.
Crossref
Crossref
David Osoba, Andrea Bezjak, Michael Brundage & Joseph Pater. (2007) Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience. Value in Health 10, pages S138-S145.
Crossref
Crossref
Giuseppe Di Lorenzo, Panagiotis A Konstantinopoulos, Liron Pantanowitz, Rossella Di Trolio, Sabino De Placido & Bruce J Dezube. (2007) Management of AIDS-related Kaposi's sarcoma. The Lancet Oncology 8:2, pages 167-176.
Crossref
Crossref
Timothy Cooley, David Henry, Margaret Tonda, Steven Sun, Martin O'Connell & Wayne Rackoff. (2007) A Randomized, Double-Blind Study of Pegylated Liposomal Doxorubicin for the Treatment of AIDS-Related Kaposi's Sarcoma. The Oncologist 12:1, pages 114-123.
Crossref
Crossref
A. Marini, V. Kouri & U. R. Hengge. 2007. Therapiekonzepte Onkologie. Therapiekonzepte Onkologie
986
1001
.
A. Potthoff & N. H. Brockmeyer. (2006) HIV-assoziierte TumoreHIV-associated tumors. Der Hautarzt 57:11, pages 988-993.
Crossref
Crossref
L Brambilla, A Miedico, S Ferrucci, A Romanelli, M Brambati, M Vinci, L Tedeschi & V Boneschi. (2006) Combination of vinblastine and bleomycin as first line therapy in advanced classic Kaposi's sarcoma. Journal of the European Academy of Dermatology and Venereology 20:9, pages 1090-1094.
Crossref
Crossref
Tazio Vanni, Eduardo Sprinz, Marcelo Warlet Machado, Rodrigo de C. Santana, Benedito Antonio L. Fonseca & Gilberto Schwartsmann. (2006) Systemic treatment of AIDS-related Kaposi sarcoma: Current status and perspectives. Cancer Treatment Reviews 32:6, pages 445-455.
Crossref
Crossref
R. Di Trolio, G. Di Lorenzo, M. Delfino & S. De Placido. (2016) Role of Pegylated Lyposomal Doxorubicin (PLD) in Systemic Kaposi's Sarcoma: A Systematic Review. International Journal of Immunopathology and Pharmacology 19:2, pages 253-263.
Crossref
Crossref
Dennis A. Revicki. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
550
567
.
David Osoba. 2009. Outcomes Assessment in Cancer. Outcomes Assessment in Cancer
386
405
.
Susan E. Krown, Donald W. Northfelt, David Osoba & J. Simon Stewart. (2004) Use of liposomal anthracyclines in Kaposi’s sarcoma. Seminars in Oncology 31, pages 36-52.
Crossref
Crossref
Peter Hau, Klaus Fabel, Ulrike Baumgart, Petra Rümmele, Oliver Grauer, Annekatrin Bock, Christopher Dietmaier, Wolfgang Dietmaier, Jörg Dietrich, Christine Dudel, Franz Hübner, Tanya Jauch, Elisabeth Drechsel, Ingo Kleiter, Cäcile Wismeth, Anton Zellner, Alexander Brawanski, Andreas Steinbrecher, Jörg Marienhagen & Ulrich Bogdahn. (2004) Pegylated liposomal doxorubicin‐efficacy in patients with recurrent high‐grade glioma. Cancer 100:6, pages 1199-1207.
Crossref
Crossref
Ulrich R Hengge, Gudrun Tossing, Vivian Kouri & Stefan Fruehauf???. (2004) Graduated Systemic Treatment of AIDS-Associated Kaposi Sarcoma. American Journal of Cancer 3:3, pages 133-149.
Crossref
Crossref
Natasha B. Leighl, Ronald L. Burkes, Janet E. Dancey, Pedro G. Lopez, Brian P. Higgins, P.L. David Walde, Leona C. Rudinskas, Yasmin H. Rahim, Angela Rodgers, Gregory R. Pond & Frances A. Shepherd. (2003) A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer. Clinical Lung Cancer 5:2, pages 107-112.
Crossref
Crossref
E. Winquist, D.S. Ernst, D. Jonker, M.J. Moore, R. Segal, G. Lockwood & A. Rodgers. (2003) Phase II trial of pegylated-liposomal doxorubicin in the treatment of locally advanced unresectable or metastatic transitional cell carcinoma of the urothelial tract. European Journal of Cancer 39:13, pages 1866-1871.
Crossref
Crossref
Miriam Sharpe, Stephanie E. Easthope, Gillian M. Keating & Harriet M. Lamb. (2003) Spotlight on Polyethylene Glycol-Liposomal Doxorubicin in Solid and Hematological Malignancies and AIDS-Related Kaposi??s Sarcoma*. American Journal of Cancer 2:1, pages 67-72.
Crossref
Crossref
Ulrich R Hengge, Thomas Ruzicka, Stephen K Tyring, Martin Stuschke, Michael Roggendorf, Robert A Schwartz & Siegfried Seeber. (2002) Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. The Lancet Infectious Diseases 2:5, pages 281-292.
Crossref
Crossref
Miriam Sharpe, Stephanie E. Easthope, Gillian M. Keating & Harriet M. Lamb. (2002) Polyethylene Glycol-Liposomal Doxorubicin. Drugs 62:14, pages 2089-2126.
Crossref
Crossref